Evaluation of: Glycerol production (a marker of lipolysis) 2-deoxyglucose uptake (a marker of insulin signaling) DNA synthesis (a marker of proliferation) What they found: AOD-9604 stimulated lipolysis dose-dependently from 10 M, with a plateau at 10 M Full hGH stimulated lipolysis to a similar maximum, but with different kinetics AOD-9604 did not affect glucose uptake or DNA synthesis at all, whereas hGH inhibited both (the classic lipotoxic GH effect) Fragments with different sequence (from the N-terminal part of hGH) had no lipolytic effect Why it matters: This was the first publication of AOD-9604
The question for Lilly specifically is how many of those new patients it captures, and whether the stocks premium valuation was pricing in the policy headwind instead of this tailwind
Dieticians say people taking GLP-1 drugs need to read ingredient lists and talk to experts about what nutrients they needand dont need, wrote the outlet
Regulated as a cosmetic, meaning manufacturers cannot claim it cures or prevents disease
Why Genetic Predisposition Insights May Inform Your Cost-Benefit Analysis Before committing to a specific GLP-1 provider or medication, understanding your genetic predispositions in peptide pathways may help provide context for personalization discussions with a qualified healthcare provider
